BioGend Therapeutics Co., Ltd. engages in the development of medical equipment to restore bone and joint functions. Its products include bioactive bone graft material, biphasic cartilage repair implant and biological aggregates. The company was founded on July 7, 2016 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company